图宾根大学招收神经生物学博士后

Employer: University of Tübingen
Website:http://www.hih-tuebingen.de/s...
Location: Tübingen
Type: Postdoctoral
Posted: June 14, 2011
Expires: July 31, 2011
Jobs by tag(s): drosophila neurobiology neurodegeneration germany postdoctoral fellowship imaging biology synapse postdoc
Requisition number: PD_0711
job description
A Postdoctoral fellowship is available in the Research Group Synaptic Plasticity, at the Hertie-Institute for Clinical Brain Research, University of Tübingen, Germany. Our group uses the Drosophila Neuromuscular junction as model to address the molecular and cellular basis of synaptic plasticity. In particular, we focus on pathways that are normally involved in refining synaptic circuits via the “physiological” elimination of specific synapses. The misregulation of such pathways triggers massive, pathological loss of synapses. Thus, our work aims to achieve a better mechanistic understanding of altered synaptic plasticity in the diseased brain. Specifically, we are interested in characterizing which alterations are causative, and which are merely adaptations to neurodegenerative diseases.

Applicants should have a Ph.D, M.D., or equivalent doctoral degree with at least 2 years of postdoctoral research experience in Drosophila Neurobiology, Experience in imaging is an asset. Successful candidates must have a strong publication record. Experiences in the supervision of PhD students, teaching and in writing grants are an asset. Interested persons should send their curriculum vitae with a statement of research interests.

Please use PD_0711 as subject for you e-mail application. Incomplete applications will not be considered.

The University of Tübingen offers a stimulating and interactive scientific environment at the internationally competitive level. This includes for example the Max Plank Institutes for Developmental Biology and Biological Cybernetics, the Friedrich Miescher Laboratory, the Cluster of Excellence for Integrative Neuroscience (CIN) and the Center for Neurodegenerative Disorders (DZNE) as well as a Center for Rare Diseases.